Optimization of Dalbavancin in Patients With Hepatic or Renal Impairment

Pharmacology & Pharmacy
doi 10.4236/pp.2020.112004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc.

Related search

Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Evacetrapib

European Journal of Clinical Pharmacology
MedicinePharmacology
2016English

Pharmacokinetics of the Dual Melatonin Receptor Agonist Tasimelteon in Subjects With Hepatic or Renal Impairment

Journal of Clinical Pharmacology
Pharmacology
2015English

Pharmacokinetic Study of Osimertinib in Cancer Patients With Mild or Moderate Hepatic Impairment

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2019English

Bortezomib Just for Induction or Also for Maintenance in Myeloma Patients With Renal Impairment?

Haematologica
Hematology
2014English

Urinary Stones, Renal Cysts and Renal Impairment in Patients With Gout

International Journal of Contemporary Medical Research [IJCMR]
2018English

Dose of Gentamicin in Patients With Normal Renal Function and Renal Impairment

BMJ
1968English

Renal and Hepatic Profiles in Nigerian Multidrug Resistant Tuberculosis Patients With or Without HIV Co-Infection

African Journal of Clinical and Experimental Microbiology
2015English

Safety of High-Dose Daptomycin in Patients With Severe Renal Impairment

Therapeutics and Clinical Risk Management
2018English

Erratum To: Thromboprophylaxis in Patients Older Than 75 Years or With Moderate Renal Impairment Undergoing Knee or Hip Replacement Surgery

International Orthopaedics
SurgeryOrthopedicsSports Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy